Trials imminent for funded independent prescribers
UK to roll out NHS-funded pharmacist prescribers in community pharmacies, but on local soil, Australian doctors push back Pharmacist independent prescribing services will be trialled across England next year, reports …
Reduce or run out
Healthcare professionals urged to conserve tenecteplase (Metalyse) in wake of shortage due to surging global demand, to maintain continuity of supply for patients Boehringer Ingelheim Australia has advised the TGA …
High-dose PPI changes ‘effective’: PBAC
Decrease in esomeprazole and increase in pantoprazole scripts likely due to restriction changes, says PBAC, though full picture obscured by lack of OTC and private data Restriction changes established in …
A new recommendation
PBAC recommends listing of adalimumab biosimilar The PBAC has recommended the Authority Required listing of adalimumab (Yuflyma) in the form of 40 mg in 0.4 mL pre-filled syringe and pre-filled …
Pandemic spending ‘spike’ at discount pharmacies
Spending on retail and other health services swelled by almost 60% across Australian community pharmacies over the past three years, new report reveals Pharmacy spending increased by 21%–or $20 million—across …
“We put little handmade love hearts into everyone’s deliveries saying, ‘you’re not alone’.”
Ruth Parker has been voted Most Outstanding Community Pharmacist by her Beechworth community after shepherding them through the pandemic Ruth Parker, the sole proprietor of the only pharmacy in Victoria’s …
A question of risk
Interim decision knocks back cannabis downschedule proposal for research purposes, citing “risks of misuse, abuse and diversion” A delegate to the TGA has knocked back a recent proposal to introduce …
Downschedule decision on allergic rhinitis drugs
Bid to downschedule existing fixed-dose combination products containing both azelastine and fluticasone propionate rejected in interim decision An application to amend the existing S2 entries for azelastine and fluticasone propionate …
Medication errors: learning from coroners’ cases
How can pharmacists learn from incidents such as the deaths of a 19-year-old who received a 10-fold dose of haloperidol, or an opiate-naïve woman from fentanyl overdose? Reviewing the circumstances …
Local access to mRNA vaccines locked in
A new vaccine manufacturing facility will be built at Monash University as government strikes new deal An mRNA vaccine manufacturing facility will be built at Melbourne’s Monash University after the …
‘There’s a fair degree of trial and error at the moment.’
Chronic non-cancer pain is the leading indication for special access to medicinal cannabis products, despite doctors being urged not to prescribe for this indication Medicinal cannabis applications for chronic pain …